Cargando…

Associations Between Measures of Sarcopenic Obesity and Risk of Cardiovascular Disease and Mortality: A Cohort Study and Mendelian Randomization Analysis Using the UK Biobank

BACKGROUND: The “healthy obese” hypothesis suggests the risks associated with excess adiposity are reduced in those with higher muscle quality (mass/strength). Alternative possibilities include loss of muscle quality as people become unwell (reverse causality) or unmeasured confounding. METHODS AND...

Descripción completa

Detalles Bibliográficos
Autores principales: Farmer, Ruth E., Mathur, Rohini, Schmidt, A. Floriaan, Bhaskaran, Krishnan, Fatemifar, Ghazaleh, Eastwood, Sophie V., Finan, Chris, Denaxas, Spiros, Smeeth, Liam, Chaturvedi, Nish
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6662360/
https://www.ncbi.nlm.nih.gov/pubmed/31221000
http://dx.doi.org/10.1161/JAHA.118.011638
_version_ 1783439634141806592
author Farmer, Ruth E.
Mathur, Rohini
Schmidt, A. Floriaan
Bhaskaran, Krishnan
Fatemifar, Ghazaleh
Eastwood, Sophie V.
Finan, Chris
Denaxas, Spiros
Smeeth, Liam
Chaturvedi, Nish
author_facet Farmer, Ruth E.
Mathur, Rohini
Schmidt, A. Floriaan
Bhaskaran, Krishnan
Fatemifar, Ghazaleh
Eastwood, Sophie V.
Finan, Chris
Denaxas, Spiros
Smeeth, Liam
Chaturvedi, Nish
author_sort Farmer, Ruth E.
collection PubMed
description BACKGROUND: The “healthy obese” hypothesis suggests the risks associated with excess adiposity are reduced in those with higher muscle quality (mass/strength). Alternative possibilities include loss of muscle quality as people become unwell (reverse causality) or unmeasured confounding. METHODS AND RESULTS: We conducted a cohort study using the UK Biobank (n=452 931). Baseline body mass index (BMI) was used to quantify adiposity and handgrip strength (HGS) used for muscle quality. Outcomes were fatal and non‐fatal cardiovascular disease, and mortality. As a secondary analysis we used waist‐hip‐ratio or fat mass percentage instead of BMI, and skeletal muscle mass index instead of HGS. In a subsample, we used gene scores for BMI, waist‐hip‐ratio and HGS in a Mendelian randomization (MR). BMI defined obesity was associated with an increased risk of all outcomes (hazard ratio [HR] range 1.10–1.82). Low HGS was associated with increased risks of cardiovascular and all‐cause mortality (HR range 1.39–1.72). HRs for the association between low HGS and cardiovascular disease events were smaller (HR range 1.05–1.09). There was no suggestion of an interaction between HGS and BMI to support the healthy obese hypothesis. Results using other adiposity metrics were similar. There was no evidence of an association between skeletal muscle mass index and any outcome. Factorial Mendelian randomization confirmed no evidence for an interaction. Low genetically predicted HGS was associated with an increased risk of mortality (HR range 1.08–1.19). CONCLUSIONS: Our analyses do not support the healthy obese concept, with no evidence that the adverse effect of obesity on outcomes was reduced by improved muscle quality. Lower HGS was associated with increased risks of mortality in both observational and MR analyses, suggesting reverse causality may not be the sole explanation.
format Online
Article
Text
id pubmed-6662360
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-66623602019-08-02 Associations Between Measures of Sarcopenic Obesity and Risk of Cardiovascular Disease and Mortality: A Cohort Study and Mendelian Randomization Analysis Using the UK Biobank Farmer, Ruth E. Mathur, Rohini Schmidt, A. Floriaan Bhaskaran, Krishnan Fatemifar, Ghazaleh Eastwood, Sophie V. Finan, Chris Denaxas, Spiros Smeeth, Liam Chaturvedi, Nish J Am Heart Assoc Original Research BACKGROUND: The “healthy obese” hypothesis suggests the risks associated with excess adiposity are reduced in those with higher muscle quality (mass/strength). Alternative possibilities include loss of muscle quality as people become unwell (reverse causality) or unmeasured confounding. METHODS AND RESULTS: We conducted a cohort study using the UK Biobank (n=452 931). Baseline body mass index (BMI) was used to quantify adiposity and handgrip strength (HGS) used for muscle quality. Outcomes were fatal and non‐fatal cardiovascular disease, and mortality. As a secondary analysis we used waist‐hip‐ratio or fat mass percentage instead of BMI, and skeletal muscle mass index instead of HGS. In a subsample, we used gene scores for BMI, waist‐hip‐ratio and HGS in a Mendelian randomization (MR). BMI defined obesity was associated with an increased risk of all outcomes (hazard ratio [HR] range 1.10–1.82). Low HGS was associated with increased risks of cardiovascular and all‐cause mortality (HR range 1.39–1.72). HRs for the association between low HGS and cardiovascular disease events were smaller (HR range 1.05–1.09). There was no suggestion of an interaction between HGS and BMI to support the healthy obese hypothesis. Results using other adiposity metrics were similar. There was no evidence of an association between skeletal muscle mass index and any outcome. Factorial Mendelian randomization confirmed no evidence for an interaction. Low genetically predicted HGS was associated with an increased risk of mortality (HR range 1.08–1.19). CONCLUSIONS: Our analyses do not support the healthy obese concept, with no evidence that the adverse effect of obesity on outcomes was reduced by improved muscle quality. Lower HGS was associated with increased risks of mortality in both observational and MR analyses, suggesting reverse causality may not be the sole explanation. John Wiley and Sons Inc. 2019-06-21 /pmc/articles/PMC6662360/ /pubmed/31221000 http://dx.doi.org/10.1161/JAHA.118.011638 Text en © 2019 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Research
Farmer, Ruth E.
Mathur, Rohini
Schmidt, A. Floriaan
Bhaskaran, Krishnan
Fatemifar, Ghazaleh
Eastwood, Sophie V.
Finan, Chris
Denaxas, Spiros
Smeeth, Liam
Chaturvedi, Nish
Associations Between Measures of Sarcopenic Obesity and Risk of Cardiovascular Disease and Mortality: A Cohort Study and Mendelian Randomization Analysis Using the UK Biobank
title Associations Between Measures of Sarcopenic Obesity and Risk of Cardiovascular Disease and Mortality: A Cohort Study and Mendelian Randomization Analysis Using the UK Biobank
title_full Associations Between Measures of Sarcopenic Obesity and Risk of Cardiovascular Disease and Mortality: A Cohort Study and Mendelian Randomization Analysis Using the UK Biobank
title_fullStr Associations Between Measures of Sarcopenic Obesity and Risk of Cardiovascular Disease and Mortality: A Cohort Study and Mendelian Randomization Analysis Using the UK Biobank
title_full_unstemmed Associations Between Measures of Sarcopenic Obesity and Risk of Cardiovascular Disease and Mortality: A Cohort Study and Mendelian Randomization Analysis Using the UK Biobank
title_short Associations Between Measures of Sarcopenic Obesity and Risk of Cardiovascular Disease and Mortality: A Cohort Study and Mendelian Randomization Analysis Using the UK Biobank
title_sort associations between measures of sarcopenic obesity and risk of cardiovascular disease and mortality: a cohort study and mendelian randomization analysis using the uk biobank
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6662360/
https://www.ncbi.nlm.nih.gov/pubmed/31221000
http://dx.doi.org/10.1161/JAHA.118.011638
work_keys_str_mv AT farmerruthe associationsbetweenmeasuresofsarcopenicobesityandriskofcardiovasculardiseaseandmortalityacohortstudyandmendelianrandomizationanalysisusingtheukbiobank
AT mathurrohini associationsbetweenmeasuresofsarcopenicobesityandriskofcardiovasculardiseaseandmortalityacohortstudyandmendelianrandomizationanalysisusingtheukbiobank
AT schmidtafloriaan associationsbetweenmeasuresofsarcopenicobesityandriskofcardiovasculardiseaseandmortalityacohortstudyandmendelianrandomizationanalysisusingtheukbiobank
AT bhaskarankrishnan associationsbetweenmeasuresofsarcopenicobesityandriskofcardiovasculardiseaseandmortalityacohortstudyandmendelianrandomizationanalysisusingtheukbiobank
AT fatemifarghazaleh associationsbetweenmeasuresofsarcopenicobesityandriskofcardiovasculardiseaseandmortalityacohortstudyandmendelianrandomizationanalysisusingtheukbiobank
AT eastwoodsophiev associationsbetweenmeasuresofsarcopenicobesityandriskofcardiovasculardiseaseandmortalityacohortstudyandmendelianrandomizationanalysisusingtheukbiobank
AT financhris associationsbetweenmeasuresofsarcopenicobesityandriskofcardiovasculardiseaseandmortalityacohortstudyandmendelianrandomizationanalysisusingtheukbiobank
AT denaxasspiros associationsbetweenmeasuresofsarcopenicobesityandriskofcardiovasculardiseaseandmortalityacohortstudyandmendelianrandomizationanalysisusingtheukbiobank
AT smeethliam associationsbetweenmeasuresofsarcopenicobesityandriskofcardiovasculardiseaseandmortalityacohortstudyandmendelianrandomizationanalysisusingtheukbiobank
AT chaturvedinish associationsbetweenmeasuresofsarcopenicobesityandriskofcardiovasculardiseaseandmortalityacohortstudyandmendelianrandomizationanalysisusingtheukbiobank